Airing weekdays at 7:30 A.M. on

Airing weekdays at 7:30 A.M. on

There’s big decisions to be made for patients living with recurrent prostate cancer, from what’s next to treatment options, recurrence management, and more.

However, in the management of recurrent prostate cancer, conventional imaging (bone scans, CT, and MRI) have limitations.

Newer PET/CT imaging techniques can provide physicians and patients living with prostate cancer an opportunity to detect and localize recurrent disease at a much lower PSA level than conventional imaging.

The information provided by this type of PET/CT imaging may provide an opportunity for more personalized disease management.

Stay tuned as Dr. Jonathan K. Jay and his patient Peter Irving share the importance of knowing your options in the ongoing monitoring and management of recurrent prostate cancer.

 

Health, Wealth, Beauty, and Business

Bringing the best tips from the experts in Atlanta in business, beauty, wealth management, child healthcare, car shopping, and more. Each year, Atlanta’s Women’s Entrepreneurship Initiative selects 15 local female entrepreneurs for a 15-month business training program. We meet women who have grown their companies, created jobs, and broke through the glass ceiling. With some […]

iMCD is the deadliest subtype of Castleman disease. Approximately one third of patients die within five years of diagnosis, and another third die within 10 years if not treated.

There are no effective treatment options for people with unresectable or metastatic chondrosarcoma despite many attempts by multiple pharmaceutical companies over the past few decades.

Comments

comments